The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection

• Main Authors: Hao Chen (Author), Qianqian Lu (Author), Haoyue An (Author), Juntong Li (Author), Shuchu Shen (Author), Xi Zheng (Author), Wei Chen (Author), Lu Wang (Author), Jihong Li (Author), Youqin Du (Author), Yueqing Wang (Author), Xiaowen Liu (Author), Marcus Baumann (Author), Matthias Tacke (Author), Lili Zou (Author), Jun Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Escherichia coli ranks as the number one clinical isolate in the past years in China according to The China Antimicrobial Surveillance Network (CHINET), and its multidrug-resistant (MDR) pathogenic strains account for over 160 million cases of dysentery and one million deaths per year. Here, our wor...